{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:24:24Z","timestamp":1784615064955,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018234","name":"Inselspital, Universit\u00e4tsspital Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.thromres.2025.109454","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T08:00:28Z","timestamp":1757491228000},"page":"109454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical utility of thrombin generation using ST-Genesia\u00ae in patients with hereditary and acquired thrombophilia: A cross-sectional study"],"prefix":"10.1016","volume":"254","author":[{"given":"Lina","family":"Caspary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Stalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Brodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Angelillo-Scherrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Vrotniakaite-Bajerciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.thromres.2025.109454_bb0005","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109454_bb0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British Society for Haematology guideline","author":"Arachchillage","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.mcna.2025.01.008","article-title":"Thrombophilia testing in venous thromboembolism","volume":"109","author":"Vrotniakaite-Bajerciene","year":"2025","journal-title":"Med. Clin. North Am."},{"issue":"14","key":"10.1016\/j.thromres.2025.109454_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11144188","article-title":"Thrombophilia impact on treatment decisions, subsequent venous or arterial thrombosis and pregnancy-related morbidity: a retrospective single-center cohort study","volume":"11","author":"Vrotniakaite-Bajerciene","year":"2022","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.thromres.2025.109454_bb0025","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2025.109454_bb0030","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1055\/s-0040-1714334","article-title":"Clinical utilization and cost of thrombophilia testing in patients with venous thromboembolism","volume":"4","author":"Gaddh","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.thromres.2025.109454_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2022.12.001","article-title":"Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: a single-center cross-sectional study","volume":"223","author":"Vrotniakaite-Bajerciene","year":"2023","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2025.109454_bb0040","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/jth.15529","article-title":"Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine","volume":"19","author":"Depasse","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109454_bb0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"Tripodi","year":"2016","journal-title":"Clin. Chem."},{"issue":"12","key":"10.1016\/j.thromres.2025.109454_bb0050","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109454_bb0055","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.15287","article-title":"Recommendations for the measurement of thrombin generation: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"19","author":"Ninivaggi","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/rth2.12238","article-title":"Thrombin generation measurement using the ST Genesia thrombin generation system in a cohort of healthy adults: normal values and variability","volume":"3","author":"Calzavarini","year":"2019","journal-title":"Res. Pract. Thrombosis Haemostasis"},{"issue":"1","key":"10.1016\/j.thromres.2025.109454_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/rth2.12455","article-title":"ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents","volume":"5","author":"Ninivaggi","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.thromres.2025.109454_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12186050","article-title":"Thrombin generation is associated with venous thromboembolism recurrence, but not with major bleeding and death in the elderly: a prospective multicenter cohort study","volume":"12","author":"Vrotniakaite-Bajerciene","year":"2023","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.thromres.2025.109454_bb0075","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1538-7836.2008.03018.x","article-title":"High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism","volume":"6","author":"Tripodi","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation","volume":"296","author":"Hron","year":"2006","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.thromres.2025.109454_bb0085","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1538-7836.2009.03561.x","article-title":"Peak thrombin generation and subsequent venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE) study","volume":"7","author":"Lutsey","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109454_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072018","article-title":"Delayed thrombin generation is associated with minor bleedings in venous thromboembolism patients on rivaroxaban: usefulness of calibrated automated thrombography","volume":"9","author":"Zalewski","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.thromres.2025.109454_bb0095","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1055\/s-0038-1672183","article-title":"Calibrated automated thrombinography (CAT), a tool to identify patients at risk of bleeding during anticoagulant therapy: a systematic review","volume":"2","author":"Zwaveling","year":"2018","journal-title":"TH Open"},{"issue":"5","key":"10.1016\/j.thromres.2025.109454_bb0100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1538-7836.2010.03773.x","article-title":"Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels","volume":"8","author":"Lavigne-Lissalde","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109454_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2012.03.009","article-title":"Clinical and biological factors that contribute to thrombin generation in prothrombin G20210A carriers: a case-control study in a single Thrombophilia Center","volume":"129","author":"Marco","year":"2012","journal-title":"Thromb. Res."},{"issue":"5\u20136","key":"10.1016\/j.thromres.2025.109454_bb0110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.thromres.2004.06.017","article-title":"Phenotyping the haemostatic system by thrombography\u2014potential for the estimation of thrombotic risk","volume":"114","author":"Regnault","year":"2004","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2025.109454_bb0115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0043-1768712","article-title":"Antithrombin deficiency is associated with prothrombotic plasma fibrin clot phenotype","volume":"123","author":"Natorska","year":"2023","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1373\/clinchem.2005.063339","article-title":"Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency","volume":"52","author":"H\u00e9zard","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.thromres.2025.109454_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1160\/TH06-09-0530","article-title":"Protein C deficiency screening using a thrombin-generation assay","author":"H\u00e9zard","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109454_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0038-1642439","article-title":"A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma","volume":"71","author":"Duchemin","year":"1994","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109454_bb0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/s-0038-1650351","article-title":"Heightened thrombin generation in individuals with resistance to activated protein C","volume":"75","author":"Martinelli","year":"1996","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1160\/TH07-09-0581","article-title":"Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma","volume":"99","author":"Duchemin","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109454_bb0145","doi-asserted-by":"crossref","first-page":"1075121","DOI":"10.3389\/fcvm.2023.1075121","article-title":"Application of the thrombin generation assay in patients with antiphospholipid syndrome: a systematic review of the literature","volume":"10","author":"Gehlen","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.thromres.2025.109454_bb0150","first-page":"913","article-title":"Diagnosis of deep venous thrombosis and pulmonary embolism","volume":"86","author":"Wilbur","year":"2012","journal-title":"Am. Fam. Physician"},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.mayocp.2018.02.013","article-title":"Diagnosis and management of acute ischemic stroke","volume":"93","author":"Hasan","year":"2018","journal-title":"Mayo Clin. Proc."},{"issue":"21","key":"10.1016\/j.thromres.2025.109454_bb0160","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute myocardial infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2025.109454_bb0165","first-page":"362","article-title":"Lower extremity peripheral artery disease: diagnosis and treatment","volume":"99","author":"Firnhaber","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.thromres.2025.109454_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/101029","article-title":"Imaging diagnosis of splanchnic venous thrombosis","volume":"2015","author":"Rajesh","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.crad.2019.12.009","article-title":"Imaging of cerebral venous thrombosis","volume":"75","author":"Ghoneim","year":"2020","journal-title":"Clin. Radiol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109454_bb0180","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109454_bb0185","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/jth.14219","article-title":"Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH","volume":"16","author":"Khorana","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2025.109454_bb0190","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109454_bb0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109454_bb0200","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/jalm\/jfaa064","article-title":"Likelihood ratios as value proposition for diagnostic laboratory tests","volume":"5","author":"Fierz","year":"2020","journal-title":"J. Appl. Lab. Med."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jphys.2016.08.008","article-title":"Interpretation of dichotomous outcomes: sensitivity, specificity, likelihood ratios, and pre-test and post-test probability","volume":"62","author":"Kent","year":"2016","journal-title":"J. Physiother."},{"issue":"1","key":"10.1016\/j.thromres.2025.109454_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12874-024-02198-2","article-title":"Methods of determining optimal cut-point of diagnostic biomarkers with application of clinical data in ROC analysis: an update review","volume":"24","author":"Hassanzad","year":"2024","journal-title":"BMC Med. Res. Methodol."},{"issue":"8","key":"10.1016\/j.thromres.2025.109454_bb0215","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.2011.055343","article-title":"Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography","volume":"97","author":"Marchetti","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.thromres.2025.109454_bb0220","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1515\/cclm-2021-0108","article-title":"Thrombin generation in patients with COVID-19 with and without thromboprophylaxis","volume":"59","author":"Campello","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109454_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12959-022-00392-0","article-title":"Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background","volume":"20","author":"van Paridon","year":"2022","journal-title":"Thromb. J."},{"issue":"18","key":"10.1016\/j.thromres.2025.109454_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14184347","article-title":"Thrombin generation and D-dimer for prediction of disease progression and mortality in patients with metastatic gastrointestinal cancer","volume":"14","author":"Giaccherini","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.thromres.2025.109454_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146922","article-title":"Genetic determinants of thrombin generation and their relation to venous thrombosis: results from the GAIT-2 project","volume":"11","author":"Martin-Fernandez","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.thromres.2025.109454_bb0240","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.jtha.2024.12.041","article-title":"Multigene panel for thrombophilia testing in venous thromboembolism","volume":"23","author":"Verstraete","year":"2025","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109454_bb0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jth.15199","article-title":"Insight into the hypercoagulable state of high-risk thrombotic APS patients: contribution of a\u03b22GPI and aPS\/PT antibodies","volume":"19","author":"Pontara","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"06","key":"10.1016\/j.thromres.2025.109454_bb0250","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0039-1685452","article-title":"Comparison of two thrombin generation methods, CAT and ST-Genesia, in Liver Transplant Patients","volume":"119","author":"Roullet","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109454_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010069","article-title":"Comparison of acquired activated protein C resistance, using the CAT and ST-Genesia(\u00ae) analysers and three thrombin generation methods, in APS and SLE patients","volume":"11","author":"Efthymiou","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2025.109454_bb0260","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.thromres.2021.05.008","article-title":"Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence","volume":"203","author":"de Laat-Kremers","year":"2021","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109454_bb0265","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/bloodadvances.2023011938","article-title":"A thrombin-driven neural net diagnoses the antiphospholipid syndrome without the need for interruption of anticoagulation","volume":"8","author":"de Laat-Kremers","year":"2024","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.thromres.2025.109454_bb0270","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1160\/TH13-05-0360","article-title":"Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes","volume":"111","author":"Segers","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109454_bb0275","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.thromres.2008.12.033","article-title":"Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study","volume":"124","author":"Chaireti","year":"2009","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2025.109454_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12684","article-title":"Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia system","volume":"6","author":"Morimont","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482500204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482500204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:39:01Z","timestamp":1762249141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482500204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":56,"alternative-id":["S004938482500204X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109454","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of thrombin generation using ST-Genesia\u00ae in patients with hereditary and acquired thrombophilia: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109454"}}